**Specifications Table**TableSubject area*Chemistry*More specific subject area*Biochemistry*Type of data*Tables*How data was acquired*Real time quantitative reverse transcription PCR*Data format*Analyzed*Experimental factors*The expression of genes involved in apoptosis was analyzed via qRT-PCR after treatment of cells with the cross-linking agents epichlorohydrin and diepoxybutane.*Experimental features*Cells were treated with cross-linkers, and reverse transcription and amplification were performed in a single reaction with a real-time PCR system. The comparative C*~*T*~*method was used to quantify gene expression in drug-treated versus untreated cells., with actin used as the endogenous control.*Data source location*N/A*Data accessibility*Data are within this article*

**Value of the data**•Previous studies of the cytotoxic mechanism of DNA cross-linkers have often used cancer cells, which are prone to apoptosis. MCF10-A and HUVEC cells are models of non-cancer cell lines.•These data provide information about changes in the expression of several genes involved in apoptosis after treating cells with the cross-linkers epichlorohydrin (ECH) or diepoxybutane (DEB), providing insight into the pathways by which cell death results.•These data suggest mechanistic differences in the modes of action of these structurally related compounds, which are likely to be related to the observed differences in cytotoxicities and carcinogenic potentials. These findings may also be useful in the design of chemotherapeutic cross-linking agents.

1. Data {#s0005}
=======

Results from comparative C~T~ tests [@bib1], [@bib2] for MCF10-A cells treated with ECH ([Table 1](#t0005){ref-type="table"}) or DEB ([Table 2](#t0010){ref-type="table"}) and for HUVEC cells treated with DEB ([Table 3](#t0015){ref-type="table"}) are presented. Target genes are from a human apoptosis array. Positive ΔΔC~T~ values indicate downregulation; negative ΔΔC~T~ values indicate upregulation.Table 1Results from comparative C~T~ tests for MCF10-A cells treated with ECH under conditions that maximize apoptosis and minimize necrosis (2.5 mM ECH for 48 h).Table 1Target geneΔΔCт MeanΔΔCт SEt-statp-valueExpressionNBOK1.4570.4453.2750.031−5DIABLO3.6061.0203.5350.038−4PUMA4.6730.5438.6010.013−3BIM−2.1890.724−3.0220.039+5BAX2.2940.4694.8930.039−3BAK12.8400.09529.7590.001−3APAF-16.4790.39016.6200.000−6CASP-95.8590.39714.7640.000−6CASP-82.7850.23012.1300.001−4CASP-23.9490.6705.8930.027−3TANK1.0880.3353.2450.031−5BCL-25.2290.27419.0740.003−3Table 2Results from comparative C~T~ tests for MCF10-A cells treated with DEB under conditions that maximize apoptosis and minimize necrosis (2.0 mM DEB for 48 h).Table 2Target geneΔΔCт MeanΔΔCт SEt-statp-valueExpressionNBOK−1.3340.225−5.9250.027+3DIABLO−1.1210.104−10.7400.008+3PUMA5.3531.4603.6670.035−4BIM−1.3350.229−5.8210.028+3BAX3.1850.14022.6860.000−5BAK1−1.2170.094−12.9300.006+3APAF-1−2.5090.828−3.0300.038+5CASP-94.4960.20721.6800.000−7CASP-82.7620.05253.2840.000−3CASP-22.9370.06942.4590.001−3TANK4.7511.5233.1200.035−5BCL-22.3120.3676.3050.024--3Table 3Results from comparative C~T~ tests for HUVEC cells treated with DEB under conditions that maximize apoptosis and minimize necrosis (0.05 mM DEB for 24 h).Table 3Target geneΔΔCт MeanΔΔCт SEt-statp-valueExpressionNAPAF-1−2.4962.211−11.2900.000+5CASP-9−4.1976.262−0.6700.522+3CASP-8−5.1446.393−0.8000.444+3BAX−2.3250.345−67.4100.000+3CASP-21.4460.3124.6300.018−4PUMA−0.5970.102−5.8700.009+4CASP-31.7710.8082.1900.060−4BAK11.1810.3313.5700.007−6

2. Experimental design, materials and methods {#s0010}
=============================================

Drug treatment conditions were as follows: 2.0 mM DEB, 48 h and 2.5 mM ECH, 48 h for MCF10-A cells; 0.05 mM DEB, 24 h for HUVEC cells. Total RNA was purified from untreated and drug-treated cells. Reverse transcription and amplification were performed (Qiagen QuantiFast SYBR Green RT-PCR kit) with primers from the Human Apoptosis Primer Library (RealTimePrimers.com). Amplification conditions were as follows: 50 °C for 10 min, 95 °C for 5 min, 50 cycles of 95 °C for 10 s and 58 °C for 45 s in a StepOne Real-Time PCR system (Applied Biosystems).

C~T~ values were determined for each gene of interest, as well as for an internal control (actin). ∆C~T~ values were then calculated by subtracting the C~T~ value for the actin control from the C~T~ value for each gene of interest. To assess the effects of drug treatment on gene expression, the ∆∆C~T~ value was calculated for each gene of interest by subtracting the ΔC~T~ value for untreated cells from the ΔC~T~ value for drug-treated cells (ΔΔC~T~ = ΔC~T~ treated -- ΔC~T~ untreated).
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